Research Progress on Strategies for Improving the Enzyme Properties of Bacteriophage Endolysins

키워드

참고문헌 (75)

1. Loessner MJ, "Bacteriophage endolysins--current state of research and applications", Curr. Opin. Microbiol, 8, pp.480~487 (2005)
2. Young I, "Phages will out : strategies of host cell lysis", Trends Microbiol, 8, pp.120~128 (2000)
3. Nelson D, "Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme", Proc. Natl. Acad. Sci. USA, 98, pp.4107~4112 (2001)
4. Nelson DC, "Endolysins as antimicrobials", Adv. Virus Res, 83, pp.299~365 (2012)
5. Korndörfer IP, "The crystal structure of the bacteriophage PSA endolysin reveals a unique fold responsible for specific recognition of Listeria cell walls", J. Mol. Biol, 364, pp.678~689 (2006)
6. Becker SC, "The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA", FEMS Microbiol. Lett, 287, pp.185~191 (2008)
7. Pritchard DG, "LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae", Appl. Environ. Microbiol, 73, pp.7150~7154 (2007)
8. Oechslin F, "In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia", Antimicrob. Agents Chemother, 57, pp.6276~6283 (2013)
9. Shannon R, "Impacts of food matrix on bacteriophage and endolysin antimicrobial efficacy and performance", Crit. Rev. Food Sci. Nutr, 60, pp.1631~1640 (2020)
10. Schmelcher M, "Bacteriophage endolysins as novel antimicrobials", Future Microbiol, 7, pp.1147~1171 (2012)
11. Sykilinda NN, "Structure of an acinetobacter broadrange prophage endolysin reveals a C-terminal α-helix with the proposed role in activity against live bacterial cells", Viruses, 10, pp.309~ (2018)
12. Raz A, "Isolation of phage lysins that effectively kill Pseudomonas aeruginosa in mouse models of lung and skin infection", Antimicrob. Agents Chemother, 63, pp.e00024-19~ (2019)
13. Lai MJ, "Antibacterial activity of Acinetobacter baumannii phage ϕAB2endolysin(LysAB2)against both gram-positive and gram-negative bacteria", Appl. Microbiol. Biotechnol, 90, pp.529~539 (2011)
14. Walmagh M, "Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1", PLoS One, 7, pp.e36991~ (2012)
15. Briers Y, "The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144", Biochem. Biophys. Res. Commun, 383, pp.187~191 (2009)
16. Gerstmans H, "A VersaTile-driven platform for rapid hit-tolead development of engineered lysins", Sci. Adv, 6, pp.eaaz1136~ (2020)
17. Gutiérrez D, "Are phage lytic proteins the secret weapon to kill Staphylococcus aureus?", mBio, 9, pp.e01923-17~ (2018)
18. García JL, "Cloning, purification, and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin", J. Virol, 61, pp.2573~2580 (1987)
19. Pritchard DG, "The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30", Microbiology(Reading), 150, pp.2079~2087 (2004)
20. Alrafaie AM, "Enterococcal bacteriophage : A survey of the tail associated lysin landscape", Virus Res, 327, pp.199073~ (2023)
21. Paradis-Bleau C, "Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase", FEMS Microbiol. Lett, 266, pp.201~209 (2007)
22. Becker SC, "LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells", FEMS Microbiol. Lett, 294, pp.52~60 (2009)
23. Loessner MJ, "Heterogeneous endolysins in Listeria monocytogenes bacteriophages : a new class of enzymes and evidence for conserved holin genes within the siphoviral lysis cassettes", Mol. Microbiol, 16, pp.1231~1241 (1995)
24. Navarre WW, "Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity", J. Biol. Chem, 274, pp.15847~15856 (1999)
25. Pastagia M, "Lysins : the arrival of pathogen-directed anti-infectives", J. Med. Microbiol, 62, pp.1506~1516 (2013)
26. Fischetti VA, "Bacteriophage lysins as effective antibacterials", Curr. Opin. Microbiol, 11, pp.393~400 (2008)
27. Vollmer W, "Peptidoglycan structure and architecture", FEMS Microbiol. Rev, 32, pp.149~167 (2008)
28. Fernandes S, "More than a hole : the holin lethal function may be required to fully sensitize bacteria to the lytic action of canonical endolysins", Mol. Microbiol, 102, pp.92~106 (2016)
29. Ferro S, "Role of food sanitising treatments in inducing the 'viable but nonculturable' state of microorganisms", Food Control, 91, pp.321~329 (2018)
30. Maciejewska B, "Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections : an ambitious and also a realistic application?", Appl. Microbiol. Biotechnol, 102, pp.2563~2581 (2018)
31. Schuch R, "A bacteriolytic agent that detects and kills Bacillus anthracis", Nature, 418, pp.884~889 (2002)
32. Domenech M, "In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases", Antimicrob. Agents Chemother, 55, pp.4144~4148 (2011)
33. Yang H, "A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method", Sci. Rep, 5, pp.17257~ (2015)
34. Kim S, "Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa", J. Glob. Antimicrob. Resist, 22, pp.32~39 (2020)
35. Wu M, "A novel phage PD-6A3, and its endolysin Ply6A3, with extended lytic activity against Acinetobacter baumannii", Front. Microbiol, 9, pp.3302~ (2018)
36. Cheng Q, "Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci", Appl. Microbiol. Biotechnol, 74, pp.1284~1291 (2007)
37. Mayer MJ, "Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range", J. Bacteriol, 193, pp.5477~5486 (2011)
38. Schmelcher M, "Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity", Microb. Biotechnol, 4, pp.651~662 (2011)
39. Rodríguez-Rubio L, "Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase : fusions, deletions, and synergy with LysH5", Appl. Environ. Microbiol, 78, pp.2241~2248 (2012)
40. Díez-Martínez R, "Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module", Antimicrob. Agents Chemother, 57, pp.5355~5365 (2013)
41. Love MJ, "The molecular basis for Escherichia coli O157 : H7 phage FAHEc1 endolysin function and protein engineering to increase thermal stability", Viruses, 13, pp.1101~ (2021)
42. Mao J, "Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme", FEMS Microbiol Lett, 342, pp.30~36 (2013)
43. Dong Q, "Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococci", Microb. Biotechnol, 8, pp.210~220 (2015)
44. Fernandes S, "Novel chimerical endolysins with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus", Microb. Drug Resist, 18, pp.333~343 (2012)
45. Harris F, "Anionic antimicrobial peptides from eukaryotic organisms", Curr. Protein Pept. Sci, 10, pp.585~606 (2009)
46. Mahlapuu M, "Antimicrobial peptides : An emerging category of therapeutic agents", Front. Cell Infect. Microbiol, 6, pp.194~ (2016)
47. Bechinger B, "The SMART model : Soft membranes adapt and respond, also transiently, in the presence of antimicrobial peptides", J. Pept. Sci, 21, pp.346~355 (2015)
48. Briers Y, "Engineered endolysin-based"Artilysins"to combat multidrug-resistant gram-negative pathogens", mBio, 5, pp.e01379-01314~ (2014)
49. Yan G, "External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids", AMB Express, 9, pp.106~ (2019)
50. Mancoš M, "Functional expression and purification of tailor-made chimeric endolysin with the broad antibacterial spectrum", Biologia, 75, pp.2031~2043 (2020)
51. Cotter PD, "Bacteriocins-a viable alternative to antibiotics?", Nat. Rev. Microbiol, 11, pp.95~105 (2013)
52. Vincent PA, "The structure and biological aspects of peptide antibiotic microcin J25", Curr. Med. Chem, 16, pp.538~549 (2009)
53. Parks WM, "The action of the bacterial toxin, microcin B17, on DNA gyrase", Biochimie, 89, pp.500~507 (2007)
54. Heselpoth RD, "Lysocins : Bioengineered antimicrobials that deliver lysins across the outer membrane of Gram-negative bacteria", Antimicrob. Agents Chemother, 63, pp.e00342-19~ (2019)
55. Lukacik P, "Structural engineering of a phage lysin that targets gram-negative pathogens", Proc. Natl. Acad. Sci. USA, 109, pp.9857~9862 (2012)
56. Yan G, "The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly", Antonie Van Leeuwenhoek, 110, pp.1627~1635 (2017)
57. Zampara A, "Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria", Sci. Rep, 10, pp.12087~ (2020)
58. Plançon L, "Characterization of a high-affinity complex between the bacterial outer membrane protein FhuA and the phage T5 protein pb5", J. Mol. Biol, 318, pp.557~569 (2002)
59. Mozafari MR, "Nanoliposomes and their applications in food nanotechnology", J. Liposome Res, 18, pp.309~327 (2008)
60. Mozafari MR, "Recent trends in the lipid-based nanoencapsulation of antioxidants and their role in foods", J. Sci. Food Agric, 86, pp.2038~2045 (2010)
61. Alhajlan M, "Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors", Antimicrob. Agents Chemother, 57, pp.2694~2704 (2013)
62. Solleti VS, "Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients", J. Antimicrob. Chemother, 70, pp.784~796 (2015)
63. Rajendran V, "Stearylamine liposomal delivery of monensin in combination with free artemisinin eliminates blood stages of Plasmodium falciparum in culture and P. berghei infection in murine malaria", Antimicrob Agents Chemother, 60, pp.1304~1318 (2015)
64. Bai J, "Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against gram-negative bacteria", Enzyme Microb Technol, 128, pp.40~48 (2019)
65. Kaur J, "Exploring endolysin-loaded alginate-chitosan nanoparticles as future remedy for staphylococcal infections", AAPS PharmSciTech, 21, pp.233~ (2020)
66. Abouhmad A, "Immobilization to positively charged cellulose nanocrystals enhances the antibacterial activity and stability of hen egg white and T4 lysozyme", Biomacromolecules, 18, pp.1600~1608 (2017)
67. Agnihotri SA, "Recent advances on chitosan-based micro-and nanoparticles in drug delivery", J. Control Release, 100, pp.5~28 (2004)
68. Ragelle H, "Chitosan-based siRNA delivery systems", J. Control Release, 172, pp.207~218 (2013)
69. Gondil VS, "Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections", Int. J. Pharm, 573, pp.118850~ (2020)
70. Vaara, M., "Agents that increase the permeability of the outer membrane", Microbiol. Rev, 56, pp.395~411 (1992)
71. Briers Y, "Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa", J. Appl. Microbiol, 110, pp.778~785 (2011)
72. Lim JA, "Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria", J. Microbiol. Biotechnol, 24, pp.803~811 (2014)
73. Walmagh M, "Characterization of five novel endolysins from Gram-negative infecting bacteriophages", Appl. Microbiol. Biotechnol, 97, pp.4369~4375 (2013)
74. Oliveira H, "A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against gram-negative pathogens in presence of weak acids", PLoS One, 9, pp.e108376~ (2014)
75. Oliveira H, "Structural and enzymatic characterization of ABgp46, a novel phage endolysin with broad anti-Gram-negative bacterial activity", Front. Microbiol, 7, pp.208~ (2016)

관련 논문AI추천